You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adoptive Immunotherapy

Showing 1 - 25 of 3,701
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in New York (haplo-identical cells (donor), umbilical cord blood unit

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • haplo-identical cells (donor)
  • umbilical cord blood unit (CBU)
  • New York, New York
    Weill Cornell Medical College
Dec 14, 2022

Sarcoma Trial in Turin (Autologous CIK)

Recruiting
  • Sarcoma
  • Autologous CIK
  • Turin, Italy
    AOU Città della Salute e della Scienza di Torino - Presidio Infa
Aug 11, 2022

Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)

Recruiting
  • Pediatric Sarcoma, Refractory
  • Pediatric Sarcoma, Relapsed
  • GEM/DOX + TGFBi expanded NK cells
  • Tampa, Florida
  • +1 more
Jan 3, 2023

Late Complication From Kidney Transplant Trial in San Francisco (Treg infusion)

Completed
  • Late Complication From Kidney Transplant
  • Treg infusion
  • San Francisco, California
    University of California, San Francisco
Jul 11, 2022

Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and Stroke (NINDS)

Completed
  • Progressive Multifocal Leukoencephalopathy
  • PyVST
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)

Terminated
Has Results
  • Merkel Cell Polyomavirus Infection
  • Stage IV Merkel Cell Carcinoma AJCC v7
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 25, 2022

Acute Myeloid Leukemia Trial in Pittsburgh (Neukoplast™ (NK-92))

Completed
  • Acute Myeloid Leukemia
  • Neukoplast™ (NK-92)
  • Pittsburgh, Pennsylvania
    UPMC Cancer Center - Hillman Cancer Center
Mar 28, 2022

Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)

Completed
  • Haematological Malignancies
  • CD25/71 allodepleted donor T-cells
  • London, United Kingdom
  • +1 more
Jul 18, 2022

Acute Myeloid Leukemia Trial in Bayreuth, Chemnitz, Dresden (NK cells, Cytarabine)

Terminated
  • Acute Myeloid Leukemia
  • Bayreuth, Germany
  • +2 more
Aug 10, 2021

Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)

Active, not recruiting
  • Ewing Sarcoma
  • +4 more
  • Allogeneic HCT
  • Donor NK Cell Infusion
  • Milwaukee, Wisconsin
  • +1 more
Apr 5, 2022

CMV Infection After Allogenic HSCT Trial in Beijing (CMV-TCR-T cells)

Recruiting
  • CMV Infection After Allogenic HSCT
  • CMV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 5, 2021

Cytomegalovirus Infections, Hematopoietic Stem Cell Transplant, Opportunistic Infections Trial in Cleveland (CMV specific

Recruiting
  • Cytomegalovirus Infections
  • +2 more
  • CMV specific adoptive t-cells
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 26, 2022

Metastatic Breast Cancer Trial in Duarte (huMNC2-CAR44 CAR T cells, huMNC2-CAR44 CAR T cells @ RP2D)

Recruiting
  • Metastatic Breast Cancer
  • huMNC2-CAR44 CAR T cells
  • huMNC2-CAR44 CAR T cells @ RP2D
  • Duarte, California
    City of Hope Medical Center
Dec 22, 2021

Epstein-Barr Virus Infections, Cytomegalovirus Infections, Adenovirus Trial in New York (Rapidly generated virus specific T

Not yet recruiting
  • Epstein-Barr Virus Infections
  • +3 more
  • Rapidly generated virus specific T (R-MVST) cells
  • New York, New York
    Columbia University Irving Medical Center
Feb 18, 2022

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Metastatic Uveal Melanoma
  • Aldesleukin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Hepatocellular Carcinoma Trial in Beijing (adoptive immunotherapy, MWA)

Completed
  • Hepatocellular Carcinoma
  • adoptive immunotherapy
  • MWA
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Mar 2, 2021

Type 1 Diabetes Trial in San Francisco, New Haven (PolyTregs+IL-2)

Completed
  • Type 1 Diabetes Mellitus
  • PolyTregs+IL-2
  • San Francisco, California
  • +1 more
Oct 15, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 3, 2022

Sarcoma Trial in Torino (Autologous CIK Dose level 1, Autologous CIK Dose level 2, Autologous CIK Dose level 3)

Withdrawn
  • Sarcoma
  • Autologous CIK Dose level 1
  • +3 more
  • Torino, Italy
    Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoem
Dec 18, 2020

Toxicity, Drug, Adverse Drug Event, Effects of Immunotherapy Trial in Leiden (Nivolumab & Tumor Infiltrating Lymphocytes

Recruiting
  • Toxicity, Drug
  • +2 more
  • Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha
  • Leiden, Netherlands
    Leiden University Medical Center
Aug 16, 2022

Advanced Cancer, Metastatic Cancer Trial in Shanghai (biological, device, drug)

Recruiting
  • Advanced Cancer
  • Metastatic Cancer
  • Autologous Adoptive immune cells
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Pudong Medical Center
Jun 24, 2022

Leukemia Trial in Seattle (Patient-derived CD22-specific CAR T-cells also expressing an EGFRt)

Active, not recruiting
  • Leukemia
  • Patient-derived CD22-specific CAR T-cells also expressing an EGFRt
  • Seattle, Washington
    Seattle Children's Hospital
Feb 15, 2022

Viral Infection Trial in Washington, Houston (CMV/AdV /EBV/BKV specific T cells)

Recruiting
  • Viral Infection
  • CMV/AdV /EBV/BKV specific T cells
  • Washington, District of Columbia
  • +1 more
Aug 6, 2021

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Completed
Has Results
  • Stage III Cutaneous Melanoma AJCC v7
  • +5 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2022

CD 19+ Acute Leukemia Trial in Seattle (T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC))

Active, not recruiting
  • CD 19+ Acute Leukemia
  • T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC)
  • Seattle, Washington
    Seattle Children's Hospital
Mar 22, 2022